Bacille-Calmette-Guerin non-responders: how to manage

Intravesical immunotherapy with bacille-Calmette-Guerin (BCG) is indicated in the treatment of high-risk and intermediate-risk non-muscle invasive bladder cancer (NMIBC). Our goal is to describe the various disease states following induction and maintenance BCG and to describe contemporary treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: von Rundstedt, Friedrich-Carl, Lerner, Seth P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708234/
https://www.ncbi.nlm.nih.gov/pubmed/26816828
http://dx.doi.org/10.3978/j.issn.2223-4683.2015.05.03

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708234/
https://www.ncbi.nlm.nih.gov/pubmed/26816828
http://dx.doi.org/10.3978/j.issn.2223-4683.2015.05.03

Ejemplares similares